One decisive therapeutic target for managing Type 2 Diabetes Mellitus (T2DM) is the Dipeptidyl Peptidase-4 (DPP-4) enzyme, which plays a key role in regulating glucose metabolism. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.